Breaking News Instant updates and real-time market news.

CLBS

Caladrius

/

+

08:07
05/19/22
05/19
08:07
05/19/22
08:07

Caladrius: IDMC recommends continuation of CLBS201 trial without modification

Caladrius Biosciences announced that the Independent Data Monitoring Committee overseeing the Phase 1b, open-label, proof-of-concept study of CLBS201 for the treatment of diabetic kidney disease has reviewed the initial safety and tolerability data from the first two, sequentially treated, patients. Based on their assessment of the data, the IDMC approved proceeding with the enrollment of the remaining four patients in the study without further review. "We are very pleased with the progress of the study and with the recommendations of the IDMC," stated Kristen K. Buck, M.D., Executive Vice President of R&D and Chief Medical Officer of Caladrius. "We find it encouraging that CLBS201 appeared to be well-tolerated based on the initial assessment of data. We look forward to continuing this study and hope to rapidly enroll the remaining patients, leading to top-line data by the first quarter of 2023."

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Provident Financial downgraded to Hold from Add at Peel Hunt » 04:54
02/03/23
02/03
04:54
02/03/23
04:54
FPLPF

Provident Financial

$1.98 /

+ (+0.00%)

Peel Hunt analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FPLPF Provident Financial
$1.98 /

+ (+0.00%)

10/20/22 Barclays
Provident Financial price target lowered to 310 GBp from 370 GBp at Barclays
10/19/22 Keefe Bruyette
Provident downgraded to Underperform from Market Perform at Keefe Bruyette
Downgrade
Merck KGaA downgraded to Sell from Buy at DZ Bank » 04:53
02/03/23
02/03
04:53
02/03/23
04:53
MKGAY

Merck KGaA

$38.36 /

+ (+0.00%)

DZ Bank analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

02/02/23 Citi
Merck KGaA downgraded to Neutral from Buy at Citi
01/06/23 Morgan Stanley
Merck KGaA upgraded to Overweight from Equal Weight at Morgan Stanley
12/14/22 UBS
Merck KGaA upgraded to Buy from Neutral at UBS
11/14/22 BofA
Merck KGaA upgraded to Buy from Neutral at BofA
Downgrade
Mercialys downgraded to Neutral from Outperform at Oddo BHF » 04:53
02/03/23
02/03
04:53
02/03/23
04:53
MEIYF

Mercialys

$10.70 /

+ (+0.00%)

Oddo BHF analyst Florent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEIYF Mercialys
$10.70 /

+ (+0.00%)

02/03/22 Goldman Sachs
Mercialys downgraded to Neutral from Buy at Goldman Sachs
Downgrade
Kinnevik downgraded to Sell from Hold at Nordea » 04:52
02/03/23
02/03
04:52
02/03/23
04:52
KNKBF

Kinnevik

$18.30 /

+4.8 (+35.56%)

Nordea analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNKBF Kinnevik
$18.30 /

+4.8 (+35.56%)

12/02/22 DNB Markets
Kinnevik downgraded to Sell from Hold at DNB Markets
10/20/22 Nordea
Kinnevik upgraded to Hold from Sell at Nordea
04/26/22 Deutsche Bank
Kinnevik price target lowered to SEK 220 from SEK 290 at Deutsche Bank
04/22/22 Danske Bank
Kinnevik upgraded to Hold from Sell at Danske Bank
Downgrade
KGHM Polska downgraded to Underweight from Equal Weight at Morgan Stanley » 04:52
02/03/23
02/03
04:52
02/03/23
04:52
KGHPF

KGHM Polska

$32.80 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGHPF KGHM Polska
$32.80 /

+ (+0.00%)

01/26/23 JPMorgan
KGHM Polska price target lowered to PLN 120 from PLN 125 at JPMorgan
12/14/22 JPMorgan
KGHM Polska price target raised to PLN 125 from PLN 100 at JPMorgan
11/21/22 JPMorgan
KGHM Polska price target lowered to PLN 100 from PLN 115 at JPMorgan
11/15/22 Erste Group
KGHM Polska downgraded to Hold from Buy at Erste Group
Downgrade
IWG downgraded to Equal Weight from Overweight at Barclays » 04:50
02/03/23
02/03
04:50
02/03/23
04:50
IWGFF

IWG

$2.41 /

+0.09 (+3.88%)

Barclays analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IWGFF IWG
$2.41 /

+0.09 (+3.88%)

11/02/22 Barclays
IWG price target lowered to 190 GBp from 230 GBp at Barclays
08/10/22 Barclays
IWG price target lowered to 230 GBp from 300 GBp at Barclays
08/10/22 Peel Hunt
IWG downgraded to Add from Buy at Peel Hunt
05/10/22 Berenberg
IWG upgraded to Buy from Hold at Berenberg
Downgrade
Electrolux downgraded to Hold from Buy at SEB Equities » 04:49
02/03/23
02/03
04:49
02/03/23
04:49
ELUXY

Electrolux

$25.90 /

-2.89 (-10.04%)

SEB Equities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELUXY Electrolux
$25.90 /

-2.89 (-10.04%)

ELUXY Electrolux
$25.90 /

-2.89 (-10.04%)

11/30/22 Exane BNP Paribas
Electrolux upgraded to Outperform from Neutral at Exane BNP Paribas
10/31/22 JPMorgan
Electrolux price target raised to SEK 116 from SEK 115 at JPMorgan
10/03/22 JPMorgan
Electrolux price target lowered to SEK 115 from SEK 120 at JPMorgan
09/20/22 JPMorgan
Electrolux price target lowered to SEK 120 from SEK 135 at JPMorgan
Downgrade
Bakkavor Group downgraded to Reduce from Hold at HSBC » 04:48
02/03/23
02/03
04:48
02/03/23
04:48
BKKVF

Bakkavor Group

$1.73 /

+ (+0.00%)

HSBC analyst Doriana…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKKVF Bakkavor Group
$1.73 /

+ (+0.00%)

11/18/22 HSBC
Bakkavor downgraded to Hold on cost pressures at HSBC
11/18/22 HSBC
Bakkavor Group downgraded to Hold from Buy at HSBC
05/27/22 Berenberg
Bakkavor Group price target lowered to 110 GBp from 125 GBp at Berenberg
03/22/22 Berenberg
Bakkavor Group price target lowered to 125 GBp from 145 GBp at Berenberg
Downgrade
Alfa Laval downgraded to Hold from Buy at DNB Markets » 04:47
02/03/23
02/03
04:47
02/03/23
04:47
ALFVY

Alfa Laval

$34.44 /

+2.265 (+7.04%)

DNB Markets analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALFVY Alfa Laval
$34.44 /

+2.265 (+7.04%)

ALFVY Alfa Laval
$34.44 /

+2.265 (+7.04%)

01/24/23 Nordea
Alfa Laval downgraded to Hold from Buy at Nordea
12/08/22 JPMorgan
Alfa Laval price target lowered to SEK 265 from SEK 270 at JPMorgan
12/08/22 Credit Suisse
Alfa Laval price target raised to SEK 275 from SEK 265 at Credit Suisse
12/08/22 Deutsche Bank
Alfa Laval initiated with a Hold at Deutsche Bank
Upgrade
Pirelli upgraded to Overweight from Equal Weight at Morgan Stanley » 04:46
02/03/23
02/03
04:46
02/03/23
04:46
PLLIF

Pirelli

$5.45 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLLIF Pirelli
$5.45 /

+ (+0.00%)

01/10/23 Deutsche Bank
Pirelli upgraded to Buy from Hold at Deutsche Bank
04/05/22 Citi
Pirelli upgraded to Buy from Neutral at Citi
02/16/22 Citi
Pirelli price target raised to EUR 6.30 from EUR 5.80 at Citi
Downgrade
SSAB AB downgraded to Equal Weight from Overweight at Morgan Stanley » 04:44
02/03/23
02/03
04:44
02/03/23
04:44
SSAAY

SSAB AB

$3.51 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSAAY SSAB AB
$3.51 /

+ (+0.00%)

02/02/23 Kepler Cheuvreux
SSAB AB downgraded to Hold from Buy at Kepler Cheuvreux
02/01/23 Barclays
SSAB AB price target raised to SEK 72 from SEK 65 at Barclays
01/30/23 Deutsche Bank
SSAB AB price target raised to SEK 71 from SEK 68 at Deutsche Bank
01/30/23 JPMorgan
SSAB AB price target raised to SEK 59 from SEK 55 at JPMorgan
SSAAY SSAB AB
$3.51 /

+ (+0.00%)

Downgrade
Friedrich Vorwerk downgraded to Hold from Buy at Berenberg » 04:43
02/03/23
02/03
04:43
02/03/23
04:43
FRVWY

Friedrich Vorwerk

$3.50 /

-0.25 (-6.67%)

Berenberg analyst Lasse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRVWY Friedrich Vorwerk
$3.50 /

-0.25 (-6.67%)

01/31/23 Jefferies
Vorwerk Group SE downgraded to Hold from Buy at Jefferies
Downgrade
Asos downgraded to Hold from Buy at Deutsche Bank » 04:40
02/03/23
02/03
04:40
02/03/23
04:40
ASOMY

Asos

$12.01 /

+0.83 (+7.42%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASOMY Asos
$12.01 /

+0.83 (+7.42%)

02/01/23 HSBC
Asos upgraded to Hold from Reduce at HSBC
01/24/23 Morgan Stanley
Asos price target raised to 730 GBp from 660 GBp at Morgan Stanley
01/13/23 JPMorgan
Asos price target lowered to 1,000 GBp from 1,170 GBp at JPMorgan
01/13/23 Societe Generale
Asos price target raised to 1,180 GBp from 1,072 GBp at Societe Generale
Downgrade
Pets at Home Group downgraded to Hold from Buy at Deutsche Bank » 04:39
02/03/23
02/03
04:39
02/03/23
04:39
PAHGF

Pets at Home Group

$3.42 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAHGF Pets at Home Group
$3.42 /

+ (+0.00%)

02/02/23 Liberum
Pets at Home Group downgraded to Hold from Buy at Liberum
11/03/22 Berenberg
Pets at Home Group price target lowered to 370 GBp from 470 GBp at Berenberg
08/09/22 Jefferies
Pets at Home Group initiated with a Buy at Jefferies
07/04/22 RBC Capital
Pets at Home Group downgraded to Underperform from Sector Perform at RBC Capital
Downgrade
Kingfisher downgraded to Hold from Buy at Deutsche Bank » 04:39
02/03/23
02/03
04:39
02/03/23
04:39
KGFHY

Kingfisher

$7.17 /

+0.26 (+3.76%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGFHY Kingfisher
$7.17 /

+0.26 (+3.76%)

12/02/22 Deutsche Bank
Kingfisher price target lowered to 275 GBp from 280 GBp at Deutsche Bank
11/17/22 JPMorgan
Kingfisher price target lowered to 210 GBp from 220 GBp at JPMorgan
11/07/22 Credit Suisse
Kingfisher downgraded to Neutral from Outperform at Credit Suisse
09/27/22 Deutsche Bank
Kingfisher price target raised to 280 GBp from 270 GBp at Deutsche Bank
Upgrade
Inditex upgraded to Hold from Sell at Deutsche Bank » 04:38
02/03/23
02/03
04:38
02/03/23
04:38
IDEXY

Inditex

$15.76 /

-0.19 (-1.19%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDEXY Inditex
$15.76 /

-0.19 (-1.19%)

12/16/22 Societe Generale
Inditex downgraded to Hold from Buy at Societe Generale
12/15/22 Deutsche Bank
Inditex price target raised to EUR 23 from EUR 22.50 at Deutsche Bank
12/02/22 Morgan Stanley
Inditex assumed with an Equal Weight at Morgan Stanley
09/15/22 Credit Suisse
Inditex price target raised to EUR 21.50 from EUR 20.50 at Credit Suisse
Upgrade
B&M European Value Retail upgraded to Buy from Hold at Deutsche Bank » 04:37
02/03/23
02/03
04:37
02/03/23
04:37
BMRRY

B&M European Value Retail

$23.34 /

+0.85 (+3.78%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMRRY B&M European Value Retail
$23.34 /

+0.85 (+3.78%)

01/06/23 JPMorgan
B&M European Value price target lowered to EUR 540 from EUR 555 at JPMorgan
01/06/23 Barclays
B&M European Value price target raised to 485 GBp from 475 GBp at Barclays
01/06/23 Deutsche Bank
B&M European Value price target raised to 460 GBp from 415 GBp at Deutsche Bank
12/30/22 Credit Suisse
Credit Suisse sees some U.K. retailers increasing guidance
Upgrade
Marks & Spencer upgraded to Buy from Hold at Deutsche Bank » 04:37
02/03/23
02/03
04:37
02/03/23
04:37
MAKSY

Marks & Spencer

$4.00 /

+0.19 (+4.99%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAKSY Marks & Spencer
$4.00 /

+0.19 (+4.99%)

MAKSY Marks & Spencer
$4.00 /

+0.19 (+4.99%)

01/13/23 Barclays
Marks & Spencer price target raised to 165 GBp from 155 GBp at Barclays
01/13/23 JPMorgan
Marks & Spencer price target raised to 115 GBp from 100 GBp at JPMorgan
01/13/23 Citi
Marks & Spencer price target raised to 150 GBp from 125 GBp at Citi
12/30/22 Credit Suisse
Credit Suisse sees some U.K. retailers increasing guidance
Upgrade
Standard Chartered upgraded to Buy from Hold at Investec » 04:34
02/03/23
02/03
04:34
02/03/23
04:34
SCBFF

Standard Chartered

$8.15 /

+ (+0.00%)

Investec analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCBFF Standard Chartered
$8.15 /

+ (+0.00%)

02/01/23 Goldman Sachs
Standard Chartered downgraded to Neutral from Buy at Goldman Sachs
01/16/23 Deutsche Bank
Standard Chartered downgraded to Hold from Buy at Deutsche Bank
01/06/23 Investec
Standard Chartered downgraded to Hold from Buy at Investec
12/06/22 JPMorgan
Standard Chartered price target raised to 800 GBp from 770 GBp at JPMorgan
Recommendations
Amazon.com price target raised to $123 from $119 at Piper Sandler » 04:32
02/03/23
02/03
04:32
02/03/23
04:32
AMZN

Amazon.com

$112.65 /

+7.48 (+7.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

02/02/23 Morgan Stanley
Meta Platforms price target raised to $190 from $130 at Morgan Stanley
02/01/23 Oppenheimer
Oppenheimer says channel checks support below-consensus AWS estimates
02/01/23 Morgan Stanley
Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley
01/30/23 UBS
Amazon's Buy with Prime puts up to 14% of Shopify revenue at risk, says UBS
AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

Recommendations
Alphabet price target lowered to $120 from $122 at Piper Sandler » 04:30
02/03/23
02/03
04:30
02/03/23
04:30
GOOGL

Alphabet

$107.71 /

+7.275 (+7.24%)

, GOOG

Alphabet

$108.77 /

+7.375 (+7.27%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

02/02/23 Morgan Stanley
Meta Platforms price target raised to $190 from $130 at Morgan Stanley
01/31/23 BofA
Alphabet price target raised to $119 at BofA ahead of earnings
01/30/23 KeyBanc
Trade Desk price target lowered to $55 from $56 at KeyBanc
01/30/23 KeyBanc
Alphabet price target lowered to $117 from $118 at KeyBanc
GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

02/02/23 Morgan Stanley
Meta Platforms price target raised to $190 from $130 at Morgan Stanley
01/31/23 BofA
Alphabet price target raised to $119 at BofA ahead of earnings
01/30/23 KeyBanc
Trade Desk price target lowered to $55 from $56 at KeyBanc
01/30/23 KeyBanc
Alphabet price target lowered to $117 from $118 at KeyBanc
GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

Recommendations
Gilead price target raised to $112 from $111 at Piper Sandler » 04:28
02/03/23
02/03
04:28
02/03/23
04:28
GILD

Gilead

$81.37 /

-2.625 (-3.13%)

Piper Sandler analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$81.37 /

-2.625 (-3.13%)

GILD Gilead
$81.37 /

-2.625 (-3.13%)

01/30/23 Truist
Truist sees potential pressure on Seagen's Padcev in Q4
01/19/23 Piper Sandler
Gilead price target raised to $111 from $104 at Piper Sandler
01/03/23 RBC Capital
RBC downgrades Gilead, says drivers need time to play out
01/03/23 RBC Capital
Gilead downgraded to Sector Perform from Outperform at RBC Capital
GILD Gilead
$81.37 /

-2.625 (-3.13%)

GILD Gilead
$81.37 /

-2.625 (-3.13%)

GILD Gilead
$81.37 /

-2.625 (-3.13%)

Recommendations
Conmed price target raised to $118 from $108 at Piper Sandler » 04:27
02/03/23
02/03
04:27
02/03/23
04:27
CNMD

Conmed

$107.27 /

+8.02 (+8.08%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNMD Conmed
$107.27 /

+8.02 (+8.08%)

CNMD Conmed
$107.27 /

+8.02 (+8.08%)

02/02/23 Piper Sandler
Conmed price target raised to $118 from $108 at Piper Sandler
10/26/22 Piper Sandler
Conmed price target lowered to $108 from $118 at Piper Sandler
10/26/22 Piper Sandler
Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem
10/14/22 Needham
Conmed price target lowered to $90 from $123 at Needham
CNMD Conmed
$107.27 /

+8.02 (+8.08%)

CNMD Conmed
$107.27 /

+8.02 (+8.08%)

Initiation
Privia Health initiated with a Buy at Goldman Sachs » 04:26
02/03/23
02/03
04:26
02/03/23
04:26
PRVA

Privia Health

$27.62 /

+0.05 (+0.18%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

01/17/23 Piper Sandler
Piper Sandler would be a buyer of Privia Health following CMS data
01/09/23 BTIG
Privia Health price target lowered to $40 from $45 at BTIG
12/08/22 Stifel
Privia Health initiated with a Buy at Stifel
12/08/22 UBS
Privia Health initiated with a Buy at UBS
PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

  • 17
    Nov
PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

Initiation
Agios Pharmaceuticals initiated with an Overweight at Piper Sandler » 04:25
02/03/23
02/03
04:25
02/03/23
04:25
AGIO

Agios Pharmaceuticals

$30.16 /

+0.74 (+2.52%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

11/17/22 Goldman Sachs
Agios Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
07/27/22 SVB Securities
Agios Pharmaceuticals upgraded to Outperform from Market Perform at SVB Securities
02/25/22 RBC Capital
Agios Pharmaceuticals price target raised to $67 from $61 at RBC Capital
02/24/22 H.C. Wainwright
Agios Pharmaceuticals price target lowered to $96 from $98 at H.C. Wainwright
AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.